Literature DB >> 31336196

Acute Venous Thromboembolism Risk Highest Within 60 Days After Discharge From the Hospital in Patients With Inflammatory Bowel Diseases.

Adam S Faye1, Timothy Wen2, Ashwin N Ananthakrishnan3, Simon Lichtiger4, Gilaad G Kaplan5, Alexander M Friedman2, Garrett Lawlor4, Jason D Wright2, Frank J Attenello6, William J Mack6, Benjamin Lebwohl4.   

Abstract

BACKGROUND & AIMS: Patients with inflammatory bowel diseases (IBDs) have a high risk of venous thromboembolism (VTE). We assessed the timing and risk factors associated with readmission to the hospital for VTE among patients with IBD.
METHODS: We collected data from the Nationwide Readmissions Database on IBD index admissions resulting in readmission to the hospital for VTE within 60 days, from 2010 through 2014. We used univariable and multivariable regression to assess risk factors associated with VTE readmission with unadjusted risk ratio (RR) and adjusted RR (aRR) as measures of effect. Time to VTE readmission was assessed in 10-day intervals, for up to 90 days.
RESULTS: We identified 872,122 index admissions of patients with IBD; 1160 resulted in readmission with VTE. More than 90% of readmissions occurred within 60 days of discharge from the index admission. Factors associated with hospital readmission with VTE included prior VTE, longer length of hospital stay, comorbidities, having a flexible sigmoidoscopy or colonoscopy at index admission, and age older than 18 years. Additional risk factors included Clostridium difficile infection at index admission (aRR, 1.47; 95% CI, 1.17-1.85) and discharge to a skilled nursing facility or intermediate care facility (aRR, 1.39; 95% CI, 1.14-1.70) or discharge with home health services (aRR, 1.65; 95% CI, 1.41-1.94).
CONCLUSIONS: Among patients admitted to the hospital with IBD, most readmissions with VTE occur within 60 days of discharge. Readmission with VTE is associated with C difficile infection and discharge to a skilled nursing facility, intermediate care facility, or with home health services. Studies are needed to evaluate the potential benefit of extending VTE prophylaxis for patients admitted to the hospital with IBD for up to 2 months after discharge, to minimize risk.
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Crohn’s Disease; NRD; Pulmonary Embolism; SNF; Ulcerative Colitis

Year:  2019        PMID: 31336196      PMCID: PMC6980437          DOI: 10.1016/j.cgh.2019.07.028

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  33 in total

1.  Venous thromboembolism: a public health concern.

Authors:  Michele G Beckman; W Craig Hooper; Sara E Critchley; Thomas L Ortel
Journal:  Am J Prev Med       Date:  2010-04       Impact factor: 5.043

2.  Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study.

Authors:  J A Heit; M D Silverstein; D N Mohr; T M Petterson; W M O'Fallon; L J Melton
Journal:  Arch Intern Med       Date:  2000-03-27

3.  Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study.

Authors:  Matthew J Grainge; Joe West; Timothy R Card
Journal:  Lancet       Date:  2010-02-08       Impact factor: 79.321

4.  Implementation of a Comprehensive Post-Discharge Venous Thromboembolism Prophylaxis Program for Abdominal and Pelvic Surgery Patients.

Authors:  Peter A Najjar; Arin L Madenci; Cheryl K Zogg; Eric B Schneider; Christian A Dankers; Marc T Pimentel; Amrita S Chabria; Joel E Goldberg; Gaurav Sharma; Gregory Piazza; Ronald Bleday; Dennis P Orgill; Allen Kachalia
Journal:  J Am Coll Surg       Date:  2016-09-28       Impact factor: 6.113

5.  Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients.

Authors:  Geoffrey C Nguyen; Justina Sam
Journal:  Am J Gastroenterol       Date:  2008-08-05       Impact factor: 10.864

6.  Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?

Authors:  W Miehsler; W Reinisch; E Valic; W Osterode; W Tillinger; T Feichtenschlager; J Grisar; K Machold; S Scholz; H Vogelsang; G Novacek
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

7.  Postpartum venous thromboembolism readmissions in the United States.

Authors:  Timothy Wen; Jason D Wright; Dena Goffman; Mary E D'Alton; William J Mack; Frank J Attenello; Alexander M Friedman
Journal:  Am J Obstet Gynecol       Date:  2018-07-11       Impact factor: 8.661

8.  Obesity Is Independently Associated With Higher Annual Burden and Costs of Hospitalization in Patients With Inflammatory Bowel Diseases.

Authors:  Nghia H Nguyen; Lucila Ohno-Machado; William J Sandborn; Siddharth Singh
Journal:  Clin Gastroenterol Hepatol       Date:  2018-09-28       Impact factor: 11.382

9.  Hospitalizations for Crohn's Disease - United States, 2003-2013.

Authors:  Christopher A Malarcher; Anne G Wheaton; Yong Liu; Sujay F Greenlund; Suraj J Greenlund; Hua Lu; Janet B Croft
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-04-14       Impact factor: 17.586

10.  Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study.

Authors:  Siân Sweetland; Jane Green; Bette Liu; Amy Berrington de González; Marianne Canonico; Gillian Reeves; Valerie Beral
Journal:  BMJ       Date:  2009-12-03
View more
  9 in total

1.  Minor Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients with Inflammatory Bowel Disease.

Authors:  Adam S Faye; Kenneth W Hung; Kimberly Cheng; John W Blackett; Anna Sophia Mckenney; Adam R Pont; Jianhua Li; Garrett Lawlor; Benjamin Lebwohl; Daniel E Freedberg
Journal:  Inflamm Bowel Dis       Date:  2020-08-20       Impact factor: 5.325

Review 2.  Cerebral Venous Sinus Thrombosis in Inflammatory Bowel Disease: A Review of Published Case Reports.

Authors:  Aishah Ibrahim Albakr; Noor AlMohish
Journal:  Perm J       Date:  2021-06-02

3.  International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease.

Authors:  Pablo A Olivera; Stephane Zuily; Paulo G Kotze; Veronique Regnault; Sameer Al Awadhi; Peter Bossuyt; Richard B Gearry; Subrata Ghosh; Taku Kobayashi; Patrick Lacolley; Edouard Louis; Fernando Magro; Siew C Ng; Alfredo Papa; Tim Raine; Fabio V Teixeira; David T Rubin; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-08-27       Impact factor: 46.802

4.  Risk of venous thromboembolism in children and adolescents with inflammatory bowel disease: A systematic review and meta-analysis.

Authors:  Xin-Yue Zhang; Hai-Cheng Dong; Wen-Fei Wang; Yao Zhang
Journal:  World J Gastroenterol       Date:  2022-04-28       Impact factor: 5.374

5.  Endoscopic activity, tissue factor and Crohn's disease: findings in clinical remission patients.

Authors:  Adriana Ribas Andrade; Tania Rubia Flores da Rocha; Carmen Lucia Ortiz-Agostinho; Iêda Nishitokukado; Alexandre Sousa Carlos; Matheus Freitas Cardoso de Azevedo; Claudio Lioshi Hashimoto; Aderson Omar Moura Cintra Damião; Flair José Carrilho; Elbio D'Amico; Aytan Miranda Sipahi; André Zonetti de Arruda Leite
Journal:  Therap Adv Gastroenterol       Date:  2020-08-03       Impact factor: 4.409

6.  Venous Thromboembolism in Pediatric Inflammatory Bowel Disease: A Case-Control Study.

Authors:  Elana B Mitchel; Sara Rosenbaum; Christopher Gaeta; Jing Huang; Leslie J Raffini; Robert N Baldassano; Michelle R Denburg; Lindsey Albenberg
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-05-01       Impact factor: 3.288

7.  Venous Thromboembolism Risk in Asian Patients with Inflammatory Bowel Disease: A Population-Based Nationwide Inception Cohort Study.

Authors:  Su Young Kim; Yeon Seo Cho; Hyun-Soo Kim; Jung Kuk Lee; Hee Man Kim; Hong Jun Park; Hyunil Kim; Jihoon Kim; Dae Ryong Kang
Journal:  Gut Liver       Date:  2021-11-18       Impact factor: 4.321

Review 8.  Venous thromboembolism in inflammatory bowel disease.

Authors:  Kimberly Cheng; Adam S Faye
Journal:  World J Gastroenterol       Date:  2020-03-28       Impact factor: 5.742

9.  Increasing Prevalence of Frailty and Its Association with Readmission and Mortality Among Hospitalized Patients with IBD.

Authors:  Adam S Faye; Timothy Wen; Ali Soroush; Ashwin N Ananthakrishnan; Ryan Ungaro; Garrett Lawlor; Frank J Attenello; William J Mack; Jean-Frederic Colombel; Benjamin Lebwohl
Journal:  Dig Dis Sci       Date:  2021-01-01       Impact factor: 3.199

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.